Riichiroh Maruyama, MD

Articles by Riichiroh Maruyama, MD

UFT Plus Cisplatin With Concurrent Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

ByYukito Ichinose, MD,Tokujiro Yano, MD,Hiroshi Asoh, MD,Hideki Yokoyama, MD,Riichiroh Maruyama, MD,Chie Ushijima, MD,Tadashi Uehara, MD,Takanori Kanematsu, MD,Tomofumi Yohena, MD,Susumu Wada, MD

July 1st 1999

A phase II study of combined-modality treatment consisting of uracil and tegafur (in a molar ratio of 4:1 [UFT]) plus cisplatin (Platinol) and concurrent radiotherapy was conducted to evaluate the activity of this regimen in

Latest Updated Articles

UFT Plus Cisplatin With Concurrent Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer
Published: July 1st 1999 | Updated:

Riichiroh Maruyama, MD

Articles by Riichiroh Maruyama, MD

UFT Plus Cisplatin With Concurrent Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

Latest Updated Articles

Trending on CancerNetwork

Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC

Career Stage and Location Found to Impact Oncology Coverage in the US

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC

What is the Impact of the SHARON Trial on Pancreatic Cancer Research?

177Lu-PSMA-I&T/223Ra Display Safety and Feasibility in Metastatic CRPC